Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samer Al Hadidi

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|October 22, 2021
Bing-Neel Syndrome: Update on the Diagnosis and TreatmentAbdelrahman Nanah, Samer Al Hadidi
Leukemia & Lymphoma|June 27, 2022
Thromboprophylaxis in multiple myelomaNishanth Thalambedu, Samer Al Hadidi
JCO Oncology Practice|May 11, 2021
Participation of Black Americans in Cancer Clinical Trials: Current Challenges and Proposed SolutionsMuhammad Awidi, Samer Al Hadidi
Clinical Case Reports|June 25, 2020
Autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemiaSamer Al Hadidi, Mark Udden
Expert Review of Anticancer Therapy|April 12, 2024
Targeting GPRC5D in multiple myelomaShatha Elemian, Samer Al Hadidi
Transplantation and Cellular Therapy|June 24, 2022
High dose (conditioning) regimens used prior to autologous stem cell transplantation in multiple myelomaMohammad O Ali, Samer Al Hadidi
Blood and Lymphatic Cancer : Targets and Therapy|September 21, 2023
Differential Diagnosis and Therapeutic Advances in Multiple Myeloma: A Review ArticleMunawwar Hussain, Sarvari Yellapragada, Samer Al Hadidi
BMJ Case Reports|November 22, 2014
Dystextia as a presentation of strokeSamer Al Hadidi, Basim Towfiq, Ghassan Bachuwa
Clinical Hematology International|September 27, 2023
Racial Disparities in Plasma Cell Leukemia Outcomes Among Hospitalized Patients in the United StatesCindy Wu, Deepa Dongarwar, Samer Al Hadidi
Blood Reviews|September 1, 2022
The use of bone-modifying agents in multiple myelomaMunawwar Hussain, Fatima Khan, Samer Al Hadidi
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Clinical Lymphoma, Myeloma & Leukemia|October 22, 2021
Bing-Neel Syndrome: Update on the Diagnosis and TreatmentAbdelrahman Nanah, Samer Al Hadidi
Leukemia & Lymphoma|June 27, 2022
Thromboprophylaxis in multiple myelomaNishanth Thalambedu, Samer Al Hadidi
JCO Oncology Practice|May 11, 2021
Participation of Black Americans in Cancer Clinical Trials: Current Challenges and Proposed SolutionsMuhammad Awidi, Samer Al Hadidi
Clinical Case Reports|June 25, 2020
Autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemiaSamer Al Hadidi, Mark Udden
Expert Review of Anticancer Therapy|April 12, 2024
Targeting GPRC5D in multiple myelomaShatha Elemian, Samer Al Hadidi
Transplantation and Cellular Therapy|June 24, 2022
High dose (conditioning) regimens used prior to autologous stem cell transplantation in multiple myelomaMohammad O Ali, Samer Al Hadidi
Blood and Lymphatic Cancer : Targets and Therapy|September 21, 2023
Differential Diagnosis and Therapeutic Advances in Multiple Myeloma: A Review ArticleMunawwar Hussain, Sarvari Yellapragada, Samer Al Hadidi
BMJ Case Reports|November 22, 2014
Dystextia as a presentation of strokeSamer Al Hadidi, Basim Towfiq, Ghassan Bachuwa
Clinical Hematology International|September 27, 2023
Racial Disparities in Plasma Cell Leukemia Outcomes Among Hospitalized Patients in the United StatesCindy Wu, Deepa Dongarwar, Samer Al Hadidi
Blood Reviews|September 1, 2022
The use of bone-modifying agents in multiple myelomaMunawwar Hussain, Fatima Khan, Samer Al Hadidi
Pageof 10